Harbor Capital Advisors Inc. Buys 156 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Harbor Capital Advisors Inc. increased its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 1.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,344 shares of the company’s stock after purchasing an additional 156 shares during the period. Harbor Capital Advisors Inc.’s holdings in U.S. Physical Therapy were worth $1,450,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Precision Wealth Strategies LLC lifted its holdings in U.S. Physical Therapy by 5.1% in the third quarter. Precision Wealth Strategies LLC now owns 2,824 shares of the company’s stock valued at $239,000 after buying an additional 137 shares during the period. Martin Capital Advisors LLP boosted its position in shares of U.S. Physical Therapy by 1.6% in the 3rd quarter. Martin Capital Advisors LLP now owns 13,138 shares of the company’s stock worth $1,112,000 after purchasing an additional 201 shares during the last quarter. First Horizon Advisors Inc. grew its stake in shares of U.S. Physical Therapy by 25.1% during the third quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock worth $126,000 after purchasing an additional 298 shares during the period. Canada Pension Plan Investment Board bought a new stake in U.S. Physical Therapy in the second quarter valued at about $28,000. Finally, The Manufacturers Life Insurance Company lifted its stake in U.S. Physical Therapy by 4.5% in the second quarter. The Manufacturers Life Insurance Company now owns 7,248 shares of the company’s stock valued at $670,000 after buying an additional 309 shares during the period.

Analysts Set New Price Targets

A number of brokerages have recently commented on USPH. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price target for the company from $100.00 to $115.00 in a research note on Monday, December 16th. Barrington Research reiterated an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a report on Thursday, November 21st. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. JMP Securities assumed coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective for the company. Finally, JPMorgan Chase & Co. lifted their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, U.S. Physical Therapy presently has a consensus rating of “Buy” and an average price target of $114.00.

U.S. Physical Therapy Trading Down 2.3 %

Shares of NYSE:USPH opened at $86.99 on Monday. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of 92.54, a PEG ratio of 4.23 and a beta of 1.48. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63. The company’s fifty day simple moving average is $92.83 and its 200 day simple moving average is $89.01. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 15th were issued a $0.44 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.02%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 187.23%.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, insider Eric Joseph Williams sold 2,000 shares of U.S. Physical Therapy stock in a transaction on Friday, November 8th. The shares were sold at an average price of $95.84, for a total value of $191,680.00. Following the sale, the insider now directly owns 14,814 shares in the company, valued at approximately $1,419,773.76. The trade was a 11.89 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Carey P. Hendrickson sold 516 shares of the stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the transaction, the chief financial officer now owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. This represents a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 7,412 shares of company stock valued at $706,605 over the last three months. Company insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.